Correlation Between DiaMedica Therapeutics and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Virax Biolabs Group, you can compare the effects of market volatilities on DiaMedica Therapeutics and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Virax Biolabs.
Diversification Opportunities for DiaMedica Therapeutics and Virax Biolabs
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between DiaMedica and Virax is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Virax Biolabs go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Virax Biolabs
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.37 times more return on investment than Virax Biolabs. However, DiaMedica Therapeutics is 2.69 times less risky than Virax Biolabs. It trades about 0.19 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.1 per unit of risk. If you would invest 389.00 in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of 177.00 from holding DiaMedica Therapeutics or generate 45.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Virax Biolabs Group
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Virax Biolabs Group |
DiaMedica Therapeutics and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Virax Biolabs
The main advantage of trading using opposite DiaMedica Therapeutics and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Virax Biolabs vs. DiaMedica Therapeutics | Virax Biolabs vs. Lyra Therapeutics | Virax Biolabs vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |